Back to search

National and Kapodistrian University of Athens

Μελέτη της αποτελεσματικότητας και της ασφάλειας χορήγησης εκλεκτικού αναστολέα της κυκλοοξυγενάσης-2 για την αντιμετώπιση του μετεγχειρητικού πόνου σε ασθενείς που υποβάλλονται σε ολική αρθροπλαστική ισχίου και γόνατος

Abstract

dc:description

Background and objective: The postoperative pain management in total hip and knee arthroplasty patients, the majority of whom are elderly people with concurrent diseases, aims at the prevention of the changes that the pain will cause to the cardiovascular system, the coagulation, the gastrointestinal system and the patients' functional recovery. The effect of the preoperative and postoperative administration of parecoxibin the postoperative pain and the need for analgetic drugs along with their possible side effectes were investigated in this study. Method: 31 ASA status I‐III patients scheduled for total hip or knee arthroplasty were randomized into 2 groups: GROUP 1: Administration of 40 mg of parecoxib (iv) in 100ml N/S 0.9%before the operation and at 12 hour intervals within a three‐day period. GROUP 2: Administration of the placebo (iv) 100ml N/S 0.9% and at 12hour intervals within a three‐day period. Postoperative analgesia was administered with the use of an electronic epidural pump with continuous infusion and patient control delivery of a combination of ropivacaine/morfine solution. The following were estimated: the intensity of the pain using the verbal numerical scale(NRS), the consumption of the analgetic solution 1, 2, 12 and 24 hours postoperative, the possible side effects per systems, the patients satisfaction of analgesia, the need for further medical treatment and the blood loss. Results: The placebo group presented substantially increased needs for analgesia in comparison to the patients to whom parecoxib was adminestered and the satisfaction of analgesia was lower. Furthermore, the side effects and the need for further medical treatment were higher in the placebo group. There was not documented any statistically important difference in the blood loss. Conclusions: The perioperative administration of parecoxib as an analgesic factor to patients submitted to total hip and knee arthroplasty in conjuction with epidural analgesia reduces the postoperative pain and does not increase the frequency of the occurrence of side effects and the perioperative blood loss.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dimitriou, Eftychia
  • Δημητρίου, Ευτυχία

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40690

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dimitriou, Eftychia; Δημητρίου, Ευτυχία. Μελέτη της αποτελεσματικότητας και της ασφάλειας χορήγησης εκλεκτικού αναστολέα της κυκλοοξυγενάσης-2 για την αντιμετώπιση του μετεγχειρητικού πόνου σε ασθενείς που υποβάλλονται σε ολική αρθροπλαστική ισχίου και γόνατος. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/40690